Published in Hepatitis Weekly, April 3rd, 2006
"Improved understanding of HCV dynamics during and after liver transplantation can be useful in optimizing antiviral therapy in transplant recipients," wrote K.A. Powers and colleagues, Los Alamos National Laboratory. "We analyzed serum HCV ribonucleic acid (RNA) levels during and after cadaveric liver transplantation in 6 HCV patients. After removal of the liver and before the new liver started producing virions, HCV RNA levels dropped with an average half-life (t(1/2)) of 0.8 hours."
The scientists observed, "Viral...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.